Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers (Q38341871)

2 September 2017

Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers (English)

1 reference

2 September 2017

Masamitsu Onda

1

1 reference

2 September 2017

Hisaki Nagai

2

1 reference

2 September 2017

Akira Yoshida

3

1 reference

2 September 2017

Shizuyo Miyamoto

4

1 reference

2 September 2017

Shin-Ichi Asaka

5

1 reference

2 September 2017

Junko Akaishi

6

1 reference

2 September 2017

Keisuke Takatsu

7

1 reference

2 September 2017

Mitsuji Nagahama

8

1 reference

2 September 2017

Kouichi Ito

9

1 reference

2 September 2017

Kazuo Shimizu

10

1 reference

2 September 2017

Mitsuru Emi

11

1 reference

2 September 2017

29 April 2004

1 reference

Journal of Human Genetics

2 September 2017

1 reference

2 September 2017

49

1 reference

2 September 2017

6

1 reference

2 September 2017

312-318

1 reference

https://scigraph.springernature.com/pub.10.1007/s10038-004-0146-3

2 September 2017

0 references

cites work

Retinoblastoma protein represses transcription by recruiting a histone deacetylase

1 reference

12 December 2020

E2F1 selects tumour cells for both life and death

1 reference

12 December 2020

The Rb/E2F pathway and cancer

1 reference

12 December 2020

E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product

1 reference

12 December 2020

E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines

1 reference

12 December 2020

The E2F transcription factor is a cellular target for the RB protein

1 reference

12 December 2020

Oncogenic capacity of the E2F1 gene

1 reference

12 December 2020

Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases

1 reference

12 December 2020

The regulation of E2F by pRB-family proteins

1 reference

12 December 2020

Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.

1 reference

12 December 2020

Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

1 reference

12 December 2020

The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions

1 reference

12 December 2020

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element

1 reference

12 December 2020

Distinct roles for E2F proteins in cell growth control and apoptosis

1 reference

12 December 2020

Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.

1 reference

12 December 2020

Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function

1 reference

12 December 2020

Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression

1 reference

12 December 2020

E2F as a regulator of keratinocyte proliferation: implications for skin tumor development

1 reference

12 December 2020

Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.

1 reference

12 December 2020

Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice

1 reference

12 December 2020

Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line

1 reference

12 December 2020

E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control

1 reference

12 December 2020

Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas

1 reference

12 December 2020

An E2F-like repressor of transcription.

1 reference

12 December 2020

Microsatellite instability in thyroid cancer: hot spots, clinicopathological implications, and prognostic significance.

1 reference

12 December 2020

Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland

1 reference

12 December 2020

E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos

1 reference

12 December 2020

Expansion of microsatellite in the thyroid hormone receptor-alpha1 gene linked to increased receptor expression and less aggressive thyroid cancer

1 reference

12 December 2020

E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry

1 reference

12 December 2020

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

1 reference

12 December 2020

A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation

1 reference

12 December 2020

Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction

1 reference

12 December 2020

E2f3 is critical for normal cellular proliferation

1 reference

12 December 2020

Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions

1 reference

12 December 2020

Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo.

1 reference

12 December 2020

A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting

1 reference

12 December 2020

Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas

1 reference

12 December 2020

Identification by cDNA microarray of genes involved in ovarian carcinogenesis

1 reference

12 December 2020

Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control

1 reference

12 December 2020

Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos

1 reference

12 December 2020

10.1007/S10038-004-0146-3

Identifiers

DOI

1 reference

2 September 2017

1 reference